North America dominates the Guiding Catheters market growth, accounting for 38% of global revenue, driven by high adoption of advanced interventional cardiology procedures, robust R&D investments, and a mature healthcare ecosystem. Europe follows with 28%, supported by stringent regulatory frameworks ensuring product quality and favorable reimbursement policies. The Asia-Pacific region emerges as the fastest-growing market, projected to expand at a CAGR of 12% through 2030, fueled by rising cardiovascular disease prevalence, improving healthcare infrastructure, and increasing disposable incomes. Latin America (8%) and the Middle East & Africa (6%) show potential due to public-private partnerships in healthcare and growing awareness, though infrastructure gaps and regulatory complexities temper growth.